Ga verder naar de inhoud

BHS - Hemato Knowledge Hub

Addressed to all the society with a specific interest in the field of hematology, the Hub allows access to seminars, webinars, lectures and gives the possibility to learn at 360 degrees and to stay on top of the latest advancements and innovations in the hematology sector.

BHS courses Hub

Pathology in iNHL: WHO 2017 classification

Presenter: Amélie Dendooven - Feb 6, 2021

Seminar 11: BHS course on pathology in Indolent Non-Hodgkin lymphomas

Language: English

Read more
BHS courses Hub

Richter Transformation

Presenter: Vanessa Van Hende - Feb 6, 2021

Seminar 11: BHS course on Richter Transformation

Language: English

Read more
BHS courses Hub

Indolent Lymphoma

Presenter: Marie Maerevoet - Feb 6, 2021

Seminar 11: BHS course on other indolent non-Hodgkin’s lymphoma (Marginal zone, cutaneous T-cell lymphomas)

Language: English

Read more
BHS GAM hub

An in-depth investigation of the causes of treatment failure in AML

Speaker: Sarah Bronte, Department of Internal Medicine & Pediatrics, Ghent University - Jan 30, 2021

Best Poster Award

36th General Annual Meeting

Language: English

Read more
BHS GAM hub

Flow Cytometric Clonality Assessment of T-lymphocytes by T-cell Receptor β-Chain Constant Region 1 Expression

Speaker: Louis Nevejan, Department of Laboratory Hematology, AZ Sint-Jan Brugge-Oostende AV, Bruges, Belgium - Jan 30, 2021

Best Poster Award

36th General Annual Meeting

Language: English

Read more
BHS GAM hub

Targeting of pyrroline-5-carboxylate reductase (PYCR) reduces drug resistance in multiple myeloma in vitro

Speaker: Inge Oudaert, Hematology & Immunology, Vrije Universiteit Brussels (VUB), Belgium - Jan 30, 2021

Best Poster Award

36th General Annual Meeting

Language: English

Read more
BHS GAM hub

FLT3m+ AML

Speaker: Dimitri Breems, ZNA Antwerpen, Belgium, Chairs: Ann Janssens & Dimitri Breems - Jan 30, 2021

Session title: Satellite 3 – Astellas: Reshaping the Management of FLT3m+ AML
with New Targeted Agents

11:30 - 12:30, 30 January, 36th General Annual Meeting

Language: English

Read more
BHS GAM hub

FLT3 Diagnostics: which Test for which Patients?

Speaker: Lucienne Michaux, UZ Leuven & KU Leuven, Belgium, Chairs: Ann Janssens & Dimitri Breems - Jan 30, 2021

Session title: Satellite 3 – Astellas: Reshaping the Management of FLT3m+ AML
with New Targeted Agents

11:30 - 12:30, 30 January, 36th General Annual Meeting

Language: English

Read more
BHS GAM hub

FLT3 Targeted Therapies (1st line and R/R)

Speaker: Sébastian Anguille, UZ Antwerpen, Belgium, Chairs: Ann Janssens & Dimitri Breems - Jan 30, 2021

Session title: Satellite 3 – Astellas: Reshaping the Management of FLT3m+ AML
with New Targeted Agents

11:30 - 12:30, 30 January, 36th General Annual Meeting

Language: English

Read more
BHS GAM hub

Liquid Biopsies for Hodgkin and DLBCL (differential) Diagnosis

Speaker: Jo Van Dorpe, UZ Gent, Belgium, Chairs: Helena Devos & Marc André - Jan 30, 2021

Laboratory Session at GAM 2021 in collaboration with the Belgian Society of Pathology

11:30 - 12:30, 30 January, 36th General Annual Meeting

Language: English

Read more
BHS GAM hub

Which RIC for which AML Patient

Speaker: Frédéric Baron, University of Liège, Belgium, Chairs: Philippe Lewalle & Sophie Servais - Jan 30, 2021

Session title: Highlights on Malignant Hematology Part 2

10:30 - 11:00, 30 January, 36th General Annual Meeting

Language: English

Read more
BHS GAM hub

MM and Immune Related Therapies

Speaker: Maria Victoria Mateos, University Hospital of Salamanca, Spain, Chairs: Ivan Van Riet & Valerie Robin - Jan 30, 2021

Session title: Highlights on Malignant Hematology Part 1

10:00 - 10:30, 30 January, 36th General Annual Meeting

Language: English

Read more